申请人:Ono Pharmaceutical Co., Ltd.
公开号:EP2481732A1
公开(公告)日:2012-08-01
The present invention relates to
(1) a compound of formula (I)
wherein all symbols have the same meanings as defined below, and
(2) a cysLT2 receptor antagonist comprising the compound of formula (I).
本发明涉及
(1) 式(I)化合物
其中所有符号的含义与下文所定义的相同,以及
(2) 包含式(I)化合物的 cysLT2 受体拮抗剂。